| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
PHAR.N0000 Stock Overview
Colombo City Holdings PLC operates in the real estate sector in Sri Lanka.
Colombo City Holdings Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | LK₨800.00 |
| 52 Week High | LK₨1,349.75 |
| 52 Week Low | LK₨707.00 |
| Beta | -0.10 |
| 1 Month Change | 2.80% |
| 3 Month Change | -17.53% |
| 1 Year Change | -38.36% |
| 3 Year Change | 2.42% |
| 5 Year Change | -18.77% |
| Change since IPO | 281.63% |
Recent News & Updates
Shareholder Returns
| PHAR.N0000 | LK Real Estate | LK Market | |
|---|---|---|---|
| 7D | -2.4% | 3.2% | 8.4% |
| 1Y | -38.4% | -25.9% | 5.8% |
Return vs Industry: PHAR.N0000 underperformed the LK Real Estate industry which returned -25.9% over the past year.
Return vs Market: PHAR.N0000 underperformed the LK Market which returned 5.8% over the past year.
Price Volatility
| PHAR.N0000 volatility | |
|---|---|
| PHAR.N0000 Average Weekly Movement | n/a |
| Real Estate Industry Average Movement | 5.3% |
| Market Average Movement | 8.6% |
| 10% most volatile stocks in LK Market | 13.6% |
| 10% least volatile stocks in LK Market | 5.0% |
Stable Share Price: Insufficient data to determine PHAR.N0000's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine PHAR.N0000's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1913 | n/a | K. Narangoda | https://ambeonholdings.com/real-estate/ |
Colombo City Holdings PLC operates in the real estate sector in Sri Lanka. It rents commercial properties and dwelling flats. The company was formerly known as The Colombo Pharmacy Company PLC and changed its name to Colombo City Holdings PLC in June 2013.
Colombo City Holdings Fundamentals Summary
| PHAR.N0000 fundamental statistics | |
|---|---|
| Market Cap | LK₨1.02b |
| Earnings (TTM) | LK₨29.26m |
| Revenue (TTM) | LK₨617.91m |
34.8x
P/E Ratio1.6x
P/S RatioIs PHAR.N0000 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHAR.N0000 income statement (TTM) | |
|---|---|
| Revenue | LK₨617.91m |
| Cost of Revenue | LK₨577.80m |
| Gross Profit | LK₨40.11m |
| Other Expenses | LK₨10.85m |
| Earnings | LK₨29.26m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 22.99 |
| Gross Margin | 6.49% |
| Net Profit Margin | 4.74% |
| Debt/Equity Ratio | 0.0% |
How did PHAR.N0000 perform over the long term?
See historical performance and comparisonDividends
6.2%
Current Dividend Yield218%
Payout RatioValuation
Is PHAR.N0000 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for PHAR.N0000?
Other financial metrics that can be useful for relative valuation.
| What is PHAR.N0000's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | LK₨1.02b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.6x |
| Enterprise Value/EBITDA | 35x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does PHAR.N0000's PE Ratio compare to its peers?
| PHAR.N0000 PE Ratio vs Peers |
|---|
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 45.3x | ||
MSL.N0000 Mercantile Shipping | 160.7x | n/a | LK₨497.2m |
ASCO.N0000 Lanka Realty Investments | 3.2x | n/a | LK₨3.2b |
ETWO.N0000 Equity Two | 10.4x | n/a | LK₨1.1b |
CSD.N0000 Seylan Developments | 6.9x | n/a | LK₨1.9b |
PHAR.N0000 Colombo City Holdings | 34.8x | n/a | LK₨1.0b |
Price-To-Earnings vs Peers: PHAR.N0000 is good value based on its Price-To-Earnings Ratio (34.8x) compared to the peer average (45.3x).
Price to Earnings Ratio vs Industry
How does PHAR.N0000's PE Ratio compare vs other companies in the Asian Real Estate Industry?
Price-To-Earnings vs Industry: PHAR.N0000 is expensive based on its Price-To-Earnings Ratio (34.8x) compared to the LK Real Estate industry average (7.2x)
Price to Earnings Ratio vs Fair Ratio
What is PHAR.N0000's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 34.8x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate PHAR.N0000's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of PHAR.N0000 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: PHAR.N0000 (LKR800) is trading above our estimate of fair value (LKR272.56)
Significantly Below Fair Value: PHAR.N0000 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Future Growth
How is Colombo City Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
12.0%
Forecasted Real Estate industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Colombo City Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine Colombo City Holdings's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
Past Performance
How has Colombo City Holdings performed over the past 5 years?
Past Performance Score
0/6Past Performance Score 0/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
-40.8%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PHAR.N0000 has a large one-off loss of LKR91.3M impacting its June 30 2022 financial results.
Growing Profit Margin: PHAR.N0000's current net profit margins (4.7%) are lower than last year (84.5%).
Past Earnings Growth Analysis
Earnings Trend: PHAR.N0000's earnings have declined by 40.8% per year over the past 5 years.
Accelerating Growth: PHAR.N0000's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PHAR.N0000 had negative earnings growth (-31.1%) over the past year, making it difficult to compare to the Real Estate industry average (4.7%).
Return on Equity
High ROE: PHAR.N0000's Return on Equity (1.5%) is considered low.
Discover strong past performing companies
Financial Health
How is Colombo City Holdings's financial position?
Financial Health Score
6/6Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Debt Coverage
Interest Coverage
Financial Position Analysis
Short Term Liabilities: PHAR.N0000's short term assets (LKR825.6M) exceed its short term liabilities (LKR50.6M).
Long Term Liabilities: PHAR.N0000's short term assets (LKR825.6M) exceed its long term liabilities (LKR25.8M).
Debt to Equity History and Analysis
Debt Level: PHAR.N0000 is debt free.
Reducing Debt: PHAR.N0000 has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.
Debt Coverage: PHAR.N0000 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: PHAR.N0000 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Dividend
What is Colombo City Holdings's current dividend yield, its reliability and sustainability?
Dividend Score
1/6Dividend Score 1/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Cash Flow Coverage
6.25%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: PHAR.N0000's dividend (6.25%) is higher than the bottom 25% of dividend payers in the LK market (2.25%).
High Dividend: PHAR.N0000's dividend (6.25%) is low compared to the top 25% of dividend payers in the LK market (8.27%).
Stability and Growth of Payments
Stable Dividend: PHAR.N0000 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: PHAR.N0000's dividend payments have increased, but the company has only paid a dividend for 8 years.
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (217.5%), PHAR.N0000's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (182.4%), PHAR.N0000's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Management
How experienced are the management team and are they aligned to shareholders interests?
6.3yrs
Average board tenure
CEO
K. Narangoda
1
Tenure
Dr. K. Sajeeva Narangoda serves as an Executive Director at Colombo City Holdings PLC since July 06, 2021 and has been its Chief Executive Officer since August 13, 2021. Dr. Narangoda was Group Chief Inves...
Board Members
Experienced Board: PHAR.N0000's board of directors are considered experienced (6.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Colombo City Holdings PLC's employee growth, exchange listings and data sources
Key Information
- Name: Colombo City Holdings PLC
- Ticker: PHAR.N0000
- Exchange: COSE
- Founded: 1913
- Industry: Real Estate Operating Companies
- Sector: Real Estate
- Implied Market Cap: LK₨1.018b
- Shares outstanding: 1.27m
- Website: https://ambeonholdings.com/real-estate/
Location
- Colombo City Holdings PLC
- No. 10, Gothami Road
- 5th Floor
- Colombo
- 8
- Sri Lanka
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/08/13 00:00 |
| End of Day Share Price | 2022/08/12 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2022/03/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.